Insights from 2023 ESMO Asia Annual Meeting

 

Gastrointestinal
18:31

Insights from 2023 ESMO Asia Annual Meeting

Enhancing IO Benefit in Upper-Aerodigestive Malignancies - Leveraging the Lessons of Histology: Pies and Monoliths

FEATURING Brian Henick
  • 114 views
  • February 23, 2024
  • 2
08:19

Insights from 2023 ESMO Asia Annual Meeting

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Older Patients With Locally Advanced Gastric Cancer

FEATURING Eiji Oki
  • 34 views
  • February 22, 2024
08:21

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analyses for Investigating Associations Between OS and Depth of Response or Duration of Response in Patients With Unresectable HCC"

FEATURING Masatoshi Kudo
  • 60 views
  • February 7, 2024
11:13

Insights from 2023 ESMO Asia Annual Meeting

Leveraging the Molecular Biology of HCC in Optimising Response to Immunotherapy

FEATURING Stephen L. Chan
  • 38 views
  • January 24, 2024
06:49

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC Patients Progressed to Atezolizumab + Bevacizumab"

FEATURING Mara Persano
  • 71 views
  • January 17, 2024
  • 1
06:53

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Activity in Patients With Advanced HCC Treated With Atezolizumab + Bevacizumab"

FEATURING Mara Persano
  • 41 views
  • January 17, 2024
06:05

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Long-Term Outcomes of Intraoperative Chemo With 5-FU for CRC Patients Receiving Curative Resection"

FEATURING Julien Taieb
  • 131 views
  • January 17, 2024
  • 1
21:46

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management of Advanced Biliary Tract Cancers"

FEATURING Masafumi Ikeda
  • 305 views
  • January 17, 2024
18:15

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

FEATURING Sun Young Rha
  • 188 views
  • January 17, 2024
  • 4
08:56

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab & Chemo for HER2+ Metastatic Gastric/GEJ Adenocarcinoma"

FEATURING Sun Young Rha
  • 142 views
  • January 17, 2024
  • 1
13:51

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Final Results of the RATIONALE-305 Study - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment of Advanced GC/GEJC"

FEATURING Ken Kato
  • 132 views
  • January 9, 2024
  • 1